A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males.
Sang-Heon ChoSeunghoon HanJong Lyul GhimMoon Suk NamSunyoung YuTaeHong ParkSinhye KimJihun BaeJae-Gook ShinPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2019)
NCT03247673.
Keyphrases
- phase iii
- double blind
- phase ii
- study protocol
- clinical trial
- placebo controlled
- image quality
- open label
- dual energy
- computed tomography
- contrast enhanced
- metastatic colorectal cancer
- randomized controlled trial
- positron emission tomography
- magnetic resonance imaging
- childhood cancer
- magnetic resonance
- young adults